The Critical Pathways of an Anticoagulation Service

Critical Pathways in Cardiology

Volumn 2, Issue 1, 2003, Pages 41-45

  Grasso Correnti, Nicole ^a   Goldszer, Robert C ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CREATININE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL PATHWAY; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; DRUG CONTRAINDICATION; HEALTH SERVICE; HUMAN; INTERNATIONAL STANDARD UNIT; INTRAVASCULAR ULTRASOUND; KIDNEY FUNCTION; LENGTH OF STAY; MEDICAL CARE; OUTPATIENT; OUTPATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PATIENT REFERRAL; PATIENT SATISFACTION; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; QUALITY CONTROL; REVIEW;

EID: 0142144217     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HPC.0000053679.19918.07     Document Type: Review

References (4)

1. Ansell JE. Out-of-hospital coagulation monitoring and management. J Thromb Thrombolysis 1999;7:191-4.
2. Campbell PM, Radensky PW, Denham CR. Economic analysis of systematic anticoagulation management vs. routine medical care for patients on oral warfarin therapy. Dis Manag Clin Outcomes 2000;2:1-8.
3. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996;348:423-8.
4. Pengo V, Legnani C, Noventa F, et al. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study. Thromb Haemost 2001;85:418-22.